Behavior Change Is Leading to Marketing Change The traditional playbook of portion size, indulgence marketing, or impulse-driven promotion does not resonate with this audience in the same way
Specific examples include: (1) pramlintide (amylin analog), which received FDA approval only after evidence standards shifted to accommodate an injectable adjunct therapy, having initially faced barriers related to delivery format and market positioning
Amgen's MariTide, which combines GLP-1 agonism with GIP antagonism, was specifically designed based on genetic evidence suggesting this combination could reduce nausea while maintaining weight loss efficacy [44]
An agonist is a molecule that mimics the activity of a naturally occurring substance in the body
Expert Medical Support Youre never alone in this process
Case management deadlines, including expert disclosures and discovery, are being established